Auckland, Auckland, New Zealand The leading representative office of defined VC is situated in the Auckland. The venture was found in Australia.
Besides, a startup needs to be aged 6-10 years to get the investment from the fund. The fund has no exact preference in a number of founders of portfolio startups. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Ocunexus Therapeutics, Cadence Biomedical, EnCoate. Among the most successful fund investment fields, there are Biotechnology, Pharmaceutical.
The fund was created by Andrew Kelly, Bill Kermode, Patrick Coyle.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the BioPacific Ventures, startups are often financed by Sand Hill Angels, Keiretsu Forum, HealthTech Capital. The meaningful sponsors for the fund in investment in the same round are GBS Ventures, Domain Associates, Western Technology Investment. In the next rounds fund is usually obtained by Square 1 Bank, RMI Partners, GBS Ventures.
Deals in the range of 10 - 50 millions dollars are the general things for fund. Speaking about the real fund results, this VC is 0 percentage points less often commits exit comparing to other organizations. The high activity for fund was in 2015. The fund is constantly included in less than 2 investment rounds annually.
Related Funds
Funds with similar focus
| Fund Name | Location |
| 2x Consumer Products Growth Partners | Chicago, Illinois, United States |
| Bechtel Corporation | Reston, United States, Virginia |
| CAIF | China, Shanghai |
| CMB International's Telecom Fund. | - |
| Copartners Asset Management Co. | - |
| Credit Mutuel | Alsace, France, Strasbourg |
| Dongsheng Bozhan Jituan | Beijing, China, Haidian |
| GC Hotel Tech | - |
| Hopstech | - |
| Ignite Social Enterprise | United Kingdom, Windsor, Windsor and Maidenhead |
| Keshif Ventures | California, San Diego, United States |
| MassMutual Ventures | - |
| nano bank | Japan, Tokyo |
| Profectus Capital | India, Maharashtra, Mumbai |
| Rogue Insight Capital | Canada, Markham, Ontario |
| RPA Holdings Japan | Japan, Tokyo |
| SharesPost Investment Management | California, Menlo Park, United States |
| WI Venture | Germany, Mainz, Rheinland-Pfalz |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Qool Therapeutics | $8M | 28 Nov 2017 | California, United States | ||
Cadence Biomedical | $1M | 25 Jun 2015 | Seattle, Washington, United States | ||
Ocunexus Therapeutics | $20M | 24 Jul 2012 | San Diego, California, United States | ||
Ocunexus Therapeutics | $19M | 18 Apr 2011 | San Diego, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Qool Therapeutics | $8M | 28 Nov 2017 | California, United States | ||
Cadence Biomedical | $1M | 25 Jun 2015 | Seattle, Washington, United States | ||
Ocunexus Therapeutics | $20M | 24 Jul 2012 | San Diego, California, United States | ||
Ocunexus Therapeutics | $19M | 18 Apr 2011 | San Diego, California, United States |
